Gloyn, A., Diatloff-Zito, C., Edghill, E., Bellanné-Chantelot, C., Nivot, S., Coutant, R., . . . Robert, J. (2006). KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Gloyn, A., C. Diatloff-Zito, E. Edghill, C. Bellanné-Chantelot, S. Nivot, R. Coutant, S. Ellard, A. Hattersley, و J. Robert. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Gloyn, A., et al. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.